Movement Alert｜DaVita HealthCare Partners Falls 17.34% in Regular Trading, Guidance Unchanged Despite Q2 Beat Combined with Berkshire Selling

Market Focus08-05

On August 5, DaVita HealthCare Partners declined 17.34% in regular trading, trading at $187.945/share, with turnover of $293 million.

On the news front, the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.61%, with revenue of $3.554 billion also exceeding the $3.496 billion estimate. However, DaVita maintained its full-year adjusted EPS guidance of $14.10 to $15.20, with the midpoint of $14.65 falling below the Street consensus of $14.88. Following consecutive significant beats in Q1 and Q2, the market had strongly anticipated a guidance raise; the unchanged outlook was interpreted as signaling decelerating earnings growth in the second half.

Adding to the pressure, SEC filings revealed Berkshire Hathaway recently sold 183,000 shares at an average price of $199.55, while still retaining approximately 28.7 million shares. Bank of America adjusted its price target to $170, well below the current trading level. The convergence of multiple bearish catalysts intensified selling pressure throughout the session.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1110526003?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110526003","market":"us","top_or_hot":-1,"title":"Movement Alert｜DaVita HealthCare Partners Falls 17.34% in Regular Trading, Guidance Unchanged Despite Q2 Beat Combined with Berkshire Selling","media":"Market Focus","content":"<p><p>On August 5, DaVita HealthCare Partners declined 17.34% in regular trading, trading at $187.945/share, with turnover of $293 million.</p><p>On the news front, the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.61%, with revenue of $3.554 billion also exceeding the $3.496 billion estimate. However, DaVita maintained its full-year adjusted EPS guidance of $14.10 to $15.20, with the midpoint of $14.65 falling below the Street consensus of $14.88. Following consecutive significant beats in Q1 and Q2, the market had strongly anticipated a guidance raise; the unchanged outlook was interpreted as signaling decelerating earnings growth in the second half.</p><p>Adding to the pressure, SEC filings revealed Berkshire Hathaway recently sold 183,000 shares at an average price of $199.55, while still retaining approximately 28.7 million shares. Bank of America adjusted its price target to $170, well below the current trading level. The convergence of multiple bearish catalysts intensified selling pressure throughout the session.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜DaVita HealthCare Partners Falls 17.34% in Regular Trading, Guidance Unchanged Despite Q2 Beat Combined with Berkshire Selling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜DaVita HealthCare Partners Falls 17.34% in Regular Trading, Guidance Unchanged Despite Q2 Beat Combined with Berkshire Selling\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-05 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 5, DaVita HealthCare Partners declined 17.34% in regular trading, trading at $187.945/share, with turnover of $293 million.</p><p>On the news front, the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.61%, with revenue of $3.554 billion also exceeding the $3.496 billion estimate. However, DaVita maintained its full-year adjusted EPS guidance of $14.10 to $15.20, with the midpoint of $14.65 falling below the Street consensus of $14.88. Following consecutive significant beats in Q1 and Q2, the market had strongly anticipated a guidance raise; the unchanged outlook was interpreted as signaling decelerating earnings growth in the second half.</p><p>Adding to the pressure, SEC filings revealed Berkshire Hathaway recently sold 183,000 shares at an average price of $199.55, while still retaining approximately 28.7 million shares. Bank of America adjusted its price target to $170, well below the current trading level. The convergence of multiple bearish catalysts intensified selling pressure throughout the session.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1110526003","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110526003","pubTimestamp":1785940510,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 5, DaVita HealthCare Partners declined 17.34% in regular trading, trading at $187.945/share, with turnover of $293 million.On the news front, the company reported Q2 adjusted EPS of $4.02,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"走势警报|DaVita HealthCare Partners 在常规交易中下跌 17.34%，尽管第二季度表现不佳，加上伯克希尔的抛售，但指引保持不变","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"On August 5, DaVita HealthCare Partners declined 17.34% in regular trading, trading at $187.945/share, with turnover of $293 million.On the news front, the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.61%, with revenue of $3.554 billion also exceeding the $3.496 billion estimate. However, DaVita maintained its full-year adjusted EPS guidance of $14.10 to $15.20, with the midpoint of $14.65 falling below the Street consensus of $14.88. Following consecutive significant beats in Q1 and Q2, the market had strongly anticipated a guidance raise; the unchanged outlook was interpreted as signaling decelerating earnings growth in the second half.Adding to the pressure, SEC filings revealed Berkshire Hathaway recently sold 183,000 shares at an average price of $199.55, while still retaining approximately 28.7 million shares. Bank of America adjusted its price target to $170, well below the current trading level. The convergence of multiple bearish catalysts intensified selling pressure throughout the session.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110526003","isCrawlerRequest":true}